Journal of Urologic Oncology

Search

Page Path

HOME
Search

Review Article

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer: Jaewoon Jeong, Jae Baek Ha, In Ho Chang; Korean J Urol Oncol. 2022;20(1):12-24. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.12; Full text PubReader ePub PDF

Original Article

The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model: Seok Ju Hong, Gwang Yong Hwang, Su Jeong Kang, Se Young Choi, Byung Hoon Chi, In Ho Chang; Korean J Urol Oncol. 2021;19(1):40-47. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.40
Cited By 3; Full text PubReader ePub PDF

Review Article

Bacillus Calmette-Guérin (BCG)-Cell Wall Skeleton as Immunotherapeutic Option for BCG-Refractory Superficial Bladder Cancer: Young Mi Whang, Da Hyeon Yoon, Gwang Yong Hwang, Young Wook Choi, In Ho Chang; Korean J Urol Oncol. 2019;17(2):88-95. Published online August 30, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.2.88
Cited By 1; Full text PubReader ePub PDF

Case Report

Treatment Case of Asymptomatic Prostate Tuberculosis That Developed After Bacillus Calmette-Guerin Intravesical Therapy in a Patient With Nonmuscle Invasive Bladder Cancer: Jong Won Kim, Suk Young Lee, Yee Jeong Kim, Sang Hee Choi; Korean J Urol Oncol. 2017;15(2):85-87. Published online August 29, 2017; DOI: https://doi.org/10.22465/kjuo.2017.15.2.85; Full text PubReader ePub PDF

Original Article

Prognostic Factors of Prophylactic Bacillus Calmette-Guerin Intravesical Instillation Therapy for Superficial Bladder Cancer: Young Hwii Ko , Hyoung Jin Kim , Hong Seok Park , Jae Heung Cho , Duck Ki Yoon; Korean J Urol Oncol. 2003;1(1):52-58. Published online March 30, 2003; PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

9,621	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
8,140	Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
7,940	Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
6,857	Robot-Assisted Radical Nephrectomy With Inferior Vena Cava Thrombectomy: A Narrative Review With Step-by-Step Procedures
6,806	The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer

Cited By 10	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By 8	Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Cited By 7	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 5	Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
Cited By 4	Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.